L-threo-Ritalinic acid is a stereochemically defined piperidine derivative and a major metabolite of methylphenidate. It serves as a pharmaceutical intermediate in the manufacturing of methylphenidate, featuring both an aromatic ring and an amino acid functional group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 54631-24-2
Neomycin EP Impurity G
pharmaceutical intermediate
(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester
pharmaceutical intermediate
6-chloro-4-(O-chlorophenyl)-2-quinazolinecarboxylic acid
pharmaceutical intermediate
Aminoacetonitrile sulfate
pharmaceutical intermediate
D-erythro-Ritalinic Acid
research compound
D-threo-ritalinic acid
pharmaceutical raw material
Alpha-Phenyl-2-piperidineacetic acid hydrochloride
pharmaceutical intermediate
Ritalinic acid
pharmaceutical intermediate
(2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-RYUDHWBXSA-N
C1CCN[C@@H](C1)[C@H](C2=CC=CC=C2)C(=O)O